Skip to content
10-K

Annual Report

BIOSTEM U.S. CORP

0001477932-12-001877

← back to feed
Filed
Jun 1, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · May 31, 2012 280.49M sh
Operating Cash Flow FY 2011 · Feb 29, 2012 −$746.07K
Operating Cash Flow FY 2011 · Feb 28, 2011 −$195.9K
Stockholders Equity FY 2011 · Feb 29, 2012 −$74.41K
Stockholders Equity FY 2011 · Feb 28, 2011 $257.98K
Stockholders Equity FY 2011 · Feb 28, 2010 −$2.4K
Total Liabilities FY 2011 · Feb 29, 2012 $90.32K
Total Liabilities FY 2011 · Feb 28, 2011 $64.37K
Current Assets FY 2011 · Feb 29, 2012 $15.9K
Current Assets FY 2011 · Feb 28, 2011 $311.85K
Total Assets FY 2011 · Feb 29, 2012 $15.9K
Total Assets FY 2011 · Feb 28, 2011 $322.35K
Sga Expense FY 2011 · Feb 29, 2012 $3.37M
Sga Expense FY 2011 · Feb 28, 2011 $192.65K
Net Income FY 2011 · Feb 29, 2012 −$3.34M
Net Income FY 2011 · Feb 28, 2011 −$179.62K
Gross Profit FY 2011 · Feb 29, 2012 $56.26K
Gross Profit FY 2011 · Feb 28, 2011 $13.02K
Cost Of Revenue FY 2011 · Feb 29, 2012 $38.49K
Cost Of Revenue FY 2011 · Feb 28, 2011 $1.68K
Revenue FY 2011 · Feb 29, 2012 $94.75K
Revenue FY 2011 · Feb 28, 2011 $14.71K